(Q39774052)

14 September 2017

Oncostatin M (OSM) is increased in asthma with incompletely reversible airflow obstruction (English)

1 reference

14 September 2017

0 references

Jodie L Simpson

1

1 reference

14 September 2017

Katherine J Baines

2

1 reference

14 September 2017

Michael J Boyle

3

1 reference

14 September 2017

Rodney J Scott

4

1 reference

14 September 2017

Peter G Gibson

5

1 reference

14 September 2017

1 November 2009

1 reference

Experimental Lung Research

14 September 2017

1 reference

14 September 2017

35

1 reference

14 September 2017

9

1 reference

14 September 2017

781-794

1 reference

Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up

14 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Severe exacerbations predict excess lung function decline in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Asthma and irreversible airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Asthma in the elderly. A comparison between patients with recently acquired and long-standing disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: a real-life study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Clinical relevance of airway remodelling in airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Oncostatin M is a mitogen for rabbit vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Exclusive neutrophil recruitment with oncostatin M in a human system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Oncostatin M: an interleukin-6-like cytokine relevant to airway remodelling and the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Inhalation provocation tests using nonisotonic aerosols

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Interleukin-10 gene expression in acute virus-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

Mortality and airflow obstruction in asthma: a 17-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902140902906412

10.3109/01902140902906412

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference